Product Information
TRIAMCINOLONE 0.025% OINT is a generic product labeled by NorthStar Rx LLC, priced at $0.0740 per GM under NDC 16714026702. Its NADAC has been published 204 times since Nov 9, 2022.
FDA first approved this application on Nov 23, 2018. Its Orange Book therapeutic-equivalence code is AT.
Strength
.25 mg/g
Manufacturer
NorthStar Rx LLCNDC
16714026702
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209828FDA Approved
11/23/2018
TE Code
AT
On Market Since
4/21/2022
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE 0.025% OINT has been published 204 times since Nov 9, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0740 per GM |
|---|---|
| All-time high | $0.0789 (Jul 10, 2024) |
| All-time low | $0.0569 (May 22, 2024) |
| 52-week high | $0.0764 |
| 52-week low | $0.0724 |
| Median price | $0.0741 |
| Average price | $0.0725 |
| Largest weekly change | +38.5% (Jun 19, 2024) |
| Weeks tracked | 204 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamcinolone acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE 0.025% OINT?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE 0.025% OINT, manufactured by NorthStar Rx LLC, is $0.0740 per GM (NDC 16714026702), effective Sep 30, 2026.
How has the price of TRIAMCINOLONE 0.025% OINT changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE 0.025% OINT has held within roughly two percent of its current level. It has been tracked across 204 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE 0.025% OINT?
Since Nov 9, 2022, the NADAC for TRIAMCINOLONE 0.025% OINT has ranged from a low of $0.0569 (May 22, 2024) to a high of $0.0789 (Jul 10, 2024), with a median of $0.0741 per GM.
Are there cheaper alternatives to TRIAMCINOLONE 0.025% OINT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMCINOLONE 0.025% OINT, is $0.0471 per GM — about 36% below TRIAMCINOLONE 0.025% OINT.
Who manufactures TRIAMCINOLONE 0.025% OINT?
TRIAMCINOLONE 0.025% OINT (NDC 16714026702) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.